← Back to Search

Probiotics and Multi-Drug Resistant Urinary Tract Infection

N/A
Waitlist Available
Research Sponsored by Ochsner Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-8 weeks after initial dose

Summary

This pilot study is a single-site randomized, double blinded placebo-controlled in females with recurrent multi-drug resistant (MDR) urinary tract infections(UTI). Our study hypothesizes that a novel probiotic strain improves antibiotic sensitivity patterns in these former MDR UTIs.

Eligible Conditions
  • Urinary Tract Infection
  • Antibiotic Resistance

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-8 weeks after initial dose
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-8 weeks after initial dose for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Bacterial isolate genomic characteristics
Change in Resistance Pattern
Secondary study objectives
Antibiotics Quantity
Healthcare visit
Length of time for change in resistance
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Probiotic + AntibioticExperimental Treatment2 Interventions
50 subjects to receive probiotic supplement once daily for 6 months in capsule form, in addition to standard antibiotic regimen for treatment of UTI.
Group II: Placebo + AntibioticActive Control2 Interventions
50 subjects to receive placebo once daily for 6 months in capsule form, in addition to antibiotic regimen for treatment of UTI.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bifidobacterium infantis
2018
Completed Phase 4
~250
Antibiotics
2017
Completed Phase 4
~5180

Find a Location

Who is running the clinical trial?

Ochsner Health SystemLead Sponsor
96 Previous Clinical Trials
91,875 Total Patients Enrolled
Procter and GambleIndustry Sponsor
147 Previous Clinical Trials
76,673 Total Patients Enrolled
1 Trials studying Urinary Tract Infection
338 Patients Enrolled for Urinary Tract Infection
~3 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top